Big Changes Are Coming in Hepatitis C

od Poordad, Fred
Izdano 2010

Treatment of Hepatitis C Virus Genotype 3 Infection

od Poordad, Fred
Izdano u Gastroenterol Hepatol (N Y) (2015)

Diagnosis, Treatment, and Monitoring of Patients With Primary Biliary Cholangitis

od Poordad, Fred
Izdano u Gastroenterol Hepatol (N Y) (2016)

Rapid Virological Response to Peginterferon Alfa and Ribavirin Treatment of Chronic Hepatitis C Predicts Sustained Virological Response and...

od Poordad, Fred, Landaverde, Carmen
Izdano 2009

Primary liver cancer surveillance, diagnosis and treatment /

od Reau, Nancy., Poordad, Fred.
Izdano 2012.

Viral Resistance in Hepatitis B: Prevalence and Management

od Poordad, Fred, Chee, Grace M.
Izdano 2010

Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetes

od Alkhouri, Naim, Poordad, Fred, Lawitz, Eric
Izdano u Hepatol Commun (2018)

Treatment of patients with hepatitis C virus genotype 3: Where are we now?

od Landaverde, Carmen, Wells, Jennifer T., Gutierrez, Julio, Poordad, Fred
Izdano u Clin Liver Dis (Hoboken) (2015)

Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient

od Gutierrez, Julio A., Landaverde, Carmen, Wells, Jennifer T., Poordad, Fred
Izdano u Hepatology (2016)

An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin

od Poordad, Fred, Lawitz, Eric, Gutierrez, Julio A., Guerrero, Juan, Speeg, Kermit, Swenson, Eugene S.
Izdano u Clin Case Rep (2017)

Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies

od Poordad, Fred, Terrault, Norah A., Alkhouri, Naim, Tian, Wei, Allen, Lee F., Rabinovitz, Mordechai
Izdano u Int J Hepatol (2020)

Ribavirin revisited in the era of direct‐acting antiviral therapy for hepatitis C virus infection

od Feld, Jordan J., Jacobson, Ira M., Sulkowski, Mark S., Poordad, Fred, Tatsch, Fernando, Pawlotsky, Jean‐Michel
Izdano u Liver Int (2016)

Association of Host Pharmacodynamic Effects with Virologic Response to Peginterferon Alfa-2a/Ribavirin in Chronic Hepatitis C

od Chung, Raymond T., Poordad, Fred F., Hassanein, Tarek, Zhou, Xiaolei, Lentz, Ellen, Prabhakar, Avinash, Di Bisceglie, Adrian M.
Izdano 2010

Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients

od Loo, Nicole, Lawitz, Eric, Alkhouri, Naim, Wells, Jennifer, Landaverde, Carmen, Coste, Angie, Salcido, Rossalynn, Scott, Michael, Poordad, Fred
Izdano u World J Gastroenterol (2019)

Percutaneous Liver Biopsy after Living Donor Liver Transplantation Resulting in Fulminant Hepatic Failure: The First Reported Case of Hepatic Compartment Syndrome

od Nissen, Nicholas N., Geller, Stephen A., Klein, Andrew, Colquhoun, Steve, Yamini, David, Tran, Tram T., Weinberg, Benjamin, Winn, Julie, Poordad, Fred
Izdano 2010

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study

od Ferrante, Shannon Allen, Chhatwal, Jagpreet, Brass, Clifford A, El Khoury, Antoine C, Poordad, Fred, Bronowicki, Jean-Pierre, Elbasha, Elamin H
Izdano 2013

High antiviral activity of NS5A inhibitor ABT‐530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection

od Poordad, Fred, Landis, Charles S., Asatryan, Armen, Jackson, Daniel F., Ng, Teresa I., Fu, Bo, Lin, Chih‐Wei, Yao, Betty, Kort, Jens
Izdano u Liver Int (2016)

Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort

od Khoudari, George, Singh, Amandeep, Noureddin, Mazen, Fritze, Danielle, Lopez, Rocio, Asaad, Imad, Lawitz, Eric, Poordad, Fred, Kowdley, Kris V, Alkhouri, Naim
Izdano u World J Hepatol (2019)

Recurrent hepatocellular carcinoma after liver transplant: identifying the high-risk patient

od Nissen, Nicholas N, Menon, Vijay, Bresee, Catherine, Tran, Tram T, Annamalai, Alagappan, Poordad, Fred, Fair, Jeffrey H, Klein, Andrew S, Boland, Brendan, Colquhoun, Steven D
Izdano 2011

Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis

od Lawitz, Eric, Poordad, Fred, Brainard, Diana M, Hyland, Robert H, An, Di, Dvory-Sobol, Hadas, Symonds, William T, McHutchison, John G, Membreno, Fernando E
Izdano u Hepatology (2015)